On November 16, 2021 Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, reported that company management will present its corporate highlights at the following upcoming virtual investor conferences (Press release, Gamida Cell, NOV 16, 2021, View Source [SID1234595713]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Evercore ISI 4th Annual HealthCONx Conference, November 30, 2021 with a presentation at 1:25 p.m. ET.
Piper Sandler 33rd Annual Virtual Healthcare Conference, December 2, 2021. Company pre-recorded fireside chat will become available to registered conference attendees on Monday, November 22, 2021 at 10:00 a.m. ET.
JMP Securities Hematology and Oncology Summit, December 6, 2021 with a fireside chat at 10:00 a.m. ET.
A webcast of each event will be available on the "Investors & Media" section of Gamida Cell’s website at www.gamida-cell.com, and will be available for at least 14 days following the event.